Sichuan Em Technology Co., Ltd.

SHSE:601208 Stock Report

Market Cap: CN¥7.4b

Sichuan Em Technology Valuation

Is 601208 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 601208 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 601208 (CN¥8.27) is trading above our estimate of fair value (CN¥2.91)

Significantly Below Fair Value: 601208 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 601208?

Key metric: As 601208 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 601208. This is calculated by dividing 601208's market cap by their current earnings.
What is 601208's PE Ratio?
PE Ratio28.4x
EarningsCN¥259.15m
Market CapCN¥7.35b

Price to Earnings Ratio vs Peers

How does 601208's PE Ratio compare to its peers?

The above table shows the PE ratio for 601208 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average55.6x
300109 Boai NKY Medical Holdings
20.3xn/aCN¥8.1b
605183 Quechen Silicon Chemical
14.8x15.4%CN¥7.2b
300848 Miracll ChemicalsLtd
111.8x80.2%CN¥7.7b
603078 Jiangyin Jianghua Microelectronics Materials
75.5x38.7%CN¥7.0b
601208 Sichuan Em Technology
28.4x36.5%CN¥7.4b

Price-To-Earnings vs Peers: 601208 is good value based on its Price-To-Earnings Ratio (28.4x) compared to the peer average (55.6x).


Price to Earnings Ratio vs Industry

How does 601208's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
601208 28.4xIndustry Avg. 38.2xNo. of Companies38PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 601208 is good value based on its Price-To-Earnings Ratio (28.4x) compared to the CN Chemicals industry average (38.2x).


Price to Earnings Ratio vs Fair Ratio

What is 601208's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

601208 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28.4x
Fair PE Ratio28.1x

Price-To-Earnings vs Fair Ratio: 601208 is expensive based on its Price-To-Earnings Ratio (28.4x) compared to the estimated Fair Price-To-Earnings Ratio (28.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 601208 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥8.27
CN¥10.20
+23.3%
15.3%CN¥11.40CN¥8.00n/a3
Dec ’25CN¥8.28
CN¥10.20
+23.2%
15.3%CN¥11.40CN¥8.00n/a3
Nov ’25CN¥8.32
CN¥9.66
+16.1%
14.9%CN¥11.40CN¥8.00n/a4
Oct ’25CN¥8.44
CN¥9.00
+6.6%
11.6%CN¥10.75CN¥8.00n/a4
Sep ’25CN¥6.67
CN¥9.00
+34.9%
11.6%CN¥10.75CN¥8.00n/a4
Aug ’25CN¥6.50
CN¥11.42
+75.6%
23.6%CN¥15.00CN¥8.50n/a3
Jul ’25CN¥7.02
CN¥12.23
+74.3%
22.3%CN¥15.00CN¥8.50n/a4
Jun ’25CN¥7.96
CN¥12.23
+53.7%
22.3%CN¥15.00CN¥8.50n/a4
May ’25CN¥8.38
CN¥12.59
+50.2%
20.2%CN¥15.00CN¥8.50n/a5
Apr ’25CN¥8.91
CN¥14.19
+59.3%
4.4%CN¥14.91CN¥13.10n/a5
Mar ’25CN¥10.79
CN¥14.19
+31.5%
4.4%CN¥14.91CN¥13.10n/a5
Feb ’25CN¥8.89
CN¥14.02
+57.6%
4.1%CN¥14.68CN¥13.10n/a4
Jan ’25CN¥12.38
CN¥14.02
+13.2%
4.1%CN¥14.68CN¥13.10n/a4
Dec ’24CN¥11.90
CN¥14.02
+17.8%
4.1%CN¥14.68CN¥13.10CN¥8.284
Nov ’24CN¥12.17
CN¥14.13
+16.1%
5.1%CN¥15.12CN¥13.10CN¥8.324
Oct ’24CN¥11.62
CN¥14.23
+22.4%
4.1%CN¥15.12CN¥13.50CN¥8.444
Sep ’24CN¥11.94
CN¥14.01
+17.3%
4.9%CN¥15.12CN¥13.40CN¥6.674
Aug ’24CN¥13.42
CN¥14.01
+4.4%
4.9%CN¥15.12CN¥13.40CN¥6.504
Jul ’24CN¥12.70
CN¥14.01
+10.3%
4.9%CN¥15.12CN¥13.40CN¥7.024
Jun ’24CN¥11.79
CN¥13.36
+13.3%
11.9%CN¥15.12CN¥10.80CN¥7.964
May ’24CN¥12.32
CN¥13.36
+8.4%
11.9%CN¥15.12CN¥10.80CN¥8.384
Apr ’24CN¥13.07
CN¥12.15
-7.0%
11.1%CN¥13.50CN¥10.80CN¥8.912
Mar ’24CN¥14.45
CN¥12.60
-12.8%
14.3%CN¥14.40CN¥10.80CN¥10.792
Feb ’24CN¥13.20
CN¥12.60
-4.5%
14.3%CN¥14.40CN¥10.80CN¥8.892
Jan ’24CN¥11.43
CN¥12.60
+10.2%
14.3%CN¥14.40CN¥10.80CN¥12.382
Dec ’23CN¥12.43
CN¥12.60
+1.4%
14.3%CN¥14.40CN¥10.80CN¥11.902

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies